RG100204
Pre-clinical- Indications
- Acute pancreatitis, Sepsis
Company intelligence / Profile preview
RG Discovery is a leading Scandinavian CRO specializing in early-stage drug discovery and advanced analytical chemistry. The company has delivered four clinical candidates to date and supports clients from hit finding through to candidate nomination. It has expertise in medicinal chemistry, computational science, in vitro biology, ADME/PK studies, and fragment-based lead discovery. The company also provides synthesis of small molecules, peptides, macrocycles, carbohydrates/conjugates/linkers/polymers as well as advanced purification and analytical services. Its client base includes pharma/biotech companies globally with repeat business indicating high satisfaction rates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RG Discovery.